IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration

References

• Vaccines against influenza WHO position paper – November 2012. Wkly Epidemiol Rec. 2012;87:461–76. PMID:23210147.
   PubMedGoogle Scholar
• Murphy BR, Clements ML. The systemic and mucosal immune response of humans to influenza A virus. Curr Top Microbiol Immunol. 1989;146:107–16. PMID:2659262.
   PubMed Web of Science ®Google Scholar
• Tamura S, Funato H, Hirabayashi Y, Kikuta K, Suzuki Y, Nagamine T, Aizawa C, Nakagawa M, Kurata T. Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza. Vaccine. 1990;8:479–85. doi:10.1016/0264-410X(90)90250-P. PMID:2251874.
   PubMed Web of Science ®Google Scholar
• Hasegawa H, Ichinohe T, Tamura S, Kurata T. Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic. Expert Rev Vaccines. 2007;6:193–201. doi:10.1586/14760584.6.2.193. PMID:17408369.
   PubMed Web of Science ®Google Scholar
• Maassab HF. Adaptation and growth characteristics of influenza virus at 25 degrees c. Nature. 1967;213:612–4. doi:10.1038/213612a0. PMID:6040602.
   PubMed Web of Science ®Google Scholar
• Waldman RH, Wood SH, Torres EJ, Small PA, Jr. Influenza antibody response following aerosal administration of inactivated virus. Am J Epidemiol. 1970;91:574–85. doi:10.1093/oxfordjournals.aje.a121170. PMID:5445644.
   PubMed Web of Science ®Google Scholar
• Wright PF, Murphy BR, Kervina M, Lawrence EM, Phelan MA, Karzon DT. Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory. Infect Immun. 1983;40:1092–5. PMID:6852914.
   PubMed Web of Science ®Google Scholar
• Tamura SI, Asanuma H, Ito Y, Hirabayashi Y, Suzuki Y, Nagamine T, Aizawa C, Kurata T, Oya A. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine. Eur J Immunol. 1992;22:477–81. doi:10.1002/eji.1830220228. PMID:1537382.
   PubMed Web of Science ®Google Scholar
• CDC. Recommendations of the Advisory Committee on Immunization Practices (ACIP): Prevention and Control of Seasonal Influenza with Vaccines. MMWR,2009;58:1–52.
   Google Scholar
• Caspard H, Gaglani M, Clipper L, Belongia EA, McLean HQ, Griffin MR, Talbot HK, Poehling KA, Peters TR, Veney N, et al. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2–17 years of age in 2013–2014 in the United States. Vaccine. 2016;34:77–82. doi:10.1016/j.vaccine.2015.11.010. PMID:26589519.
   PubMed Web of Science ®Google Scholar
• Gaglani M, Pruszynski J, Murthy K, Clipper L, Robertson A, Reis M, Chung JR, Piedra PA, Avadhanula V, Nowalk MP, et al. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013–2014 in the United States. J Infect Dis. 2016;213:1546–56. doi:10.1093/infdis/jiv577. PMID:26743842.
   PubMed Web of Science ®Google Scholar
• Penttinen PM, Friede MH. Decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines: an observational bias or a technical challenge? Euro Surveill. 2016;21:30350. doi:10.2807/1560-7917.ES.2016.21.38.30350.
   Google Scholar
• Ainai A, Tamura S, Suzuki T, van Riet E, Ito R, Odagiri T, Tashiro M, Kurata T, Hasegawa H. Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults. Hum Vaccin Immunother. 2013;9:1962–70. doi:10.4161/hv.25458. PMID:23896606.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Kawaguchi A, Ainai A, Tamura S, Ito R, Multihartina P, Setiawaty V, Pangesti KN, Odagiri T, Tashiro M, et al. Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus. Proc Natl Acad Sci U S A. 2015;112:7809–14. doi:10.1073/pnas.1503885112. PMID:26056267.
   PubMed Web of Science ®Google Scholar
• Kishida N, Fujisaki S, Yokoyama M, Sato H, Saito R, Ikematsu H, Xu H, Takashita E, Tashiro M, Takao S, et al. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs. Clin Vaccine Immunol. 2012;19:897–908. doi:10.1128/CVI.05726-11. PMID:22492743.
   PubMed Web of Science ®Google Scholar
• Woof JM, Russell MW. Structure and function relationships in IgA. Mucosal Immunol. 2011;4:590. doi:10.1038/mi.2011.39. PMID:21937984.
   PubMed Web of Science ®Google Scholar
• Crago SS, Kutteh WH, Moro I, Allansmith MR, Radl J, Haaijman JJ, Mestecky J. Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. J Immunol. 1984;132:16–8. PMID:6418796.
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human. Services Food and Drug Administration Center for Biologics Evaluation and Research. Guidance for Industry: Clinical Data Needed to Support the Licensure of Pandemic Influenza Vaccines. In: Office of Communication TaMA, Rockville, Maryland ed., 2007.
   Google Scholar
• Davenport FM, Hennessy AV, Brandon FM, Webster RG, Barrett CD, Jr., Lease GO. COMPARISONS OF SEROLOGIC AND FEBRILE RESPONSES IN HUMANS TO VACCINATION WITH INFLUENZA A VIRUSES OR THEIR HEMAGGLUTININS. J Lab Clin Med. 1964;63:5–13.
   PubMed Web of Science ®Google Scholar
• Stevens J, Corper AL, Basler CF, Taubenberger JK, Palese P, Wilson IA. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science. 2004;303:1866–70. doi:10.1126/science.1093373.
   PubMed Web of Science ®Google Scholar